SCHEMBL4683579

SCHEMBL4683579

CCCN(CC1CCN(C(N)=O)CC1)C(C)Cc1cccc(NC(=O)c2ccc(C(C)(C)C)cc2)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 3/20 0.45
ACKR3 P25106 7/20 0.44
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
SIRT3 Q9NTG7 1/20 0.41
KCNK9 Q9NPC2 1/20 0.40
PPARA Q07869 3/20 0.40
PPARG P37231 2/20 0.40
PPARD Q03181 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
TSHR P16473 1/20 0.39
F10 P00742 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PARP1 P09874 1/20 0.38
KCNK3 O14649 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8135103 0.92 NR1H4 (0.45) NR1H4ACKR3KCNK9PPARAPPARG
SCHEMBL4686021 0.91 ACKR3 (0.44) NR1H4ACKR3KCNK9PPARAPPARG
Hydrochloric Acid SCHEMBL4685699 0.89 NR1H4 (0.42) NR1H4ACKR3SIRT2SIRT1SIRT3
Trifluoroacetic Acid SCHEMBL4678472 0.89 NR1H4 (0.44) NR1H4ACKR3KCNK9PPARAPPARG
Hydrochloric Acid SCHEMBL4682704 0.89 NR1H4 (0.42) NR1H4ACKR3KCNK9PPARAPPARG
Trifluoroacetic Acid SCHEMBL4682096 0.88 NR1H4 (0.43) NR1H4ACKR3KCNK9PPARAPPARG
Trifluoroacetic Acid SCHEMBL4685661 0.88 NR1H4 (0.43) NR1H4ACKR3KCNK9PPARAPPARG
Hydrochloric Acid SCHEMBL4685299 0.88 MAPT (0.42) NR1H4ACKR3KCNK9PPARAPPARG
Trifluoroacetic Acid SCHEMBL4682457 0.88 NR1H4 (0.43) NR1H4ACKR3KCNK9PPARAPPARG
Trifluoroacetic Acid SCHEMBL4685232 0.88 NR1H4 (0.43) NR1H4ACKR3KCNK9PPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1058680-B1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP disclosed
US-6319920-B1 MUSCARINIC RECEPTOR ANTAGONIST USED IN GASTROINTESTINAL, GENITOURINARY TRACT, RESPIRATORY TRACT, CARDIOVASCULAR SYSTEM, CENTRAL NERVOUS SYSTEM DISORDERS AND IN ANESTHESIOLOGY AND OPHTHALMOLOGY SYNTEX (U.S.A.) LLC 2001-11-20 US disclosed
EP-1058680-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2000-12-13 EP disclosed
WO-1999043657-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1999-09-02 WO disclosed